维普中文期刊产品整合服务
8篇 您的检索式:作者名="Zant FM"
    题名 作者 年代 出处 被引量
1Octreotide-scintigraphy is a disease-activity parameter in Graves′ophthalmopathy显示文摘Gerding MN van der Zant FM van Royen EA 1999Clin Endocrinol(Oxf)1999,50,3:1
2Octretide- scintigraphy is a disease activity parameter in Graves' ophthalmopathy显示文摘Gerding MN Zant FM Royent EA 2002Clin Endocrinol2002,50,3:1
3A litera- ture review of SF-fluoride PET/CT and SF-choline or nC-choline PET/CT for detection of bone metastases in patients with prostate cancer显示文摘Wondergem M van der Zant FM van der Ploeg T 2013Nucl Med Commun2013,34,10:1
4Oetreotide-scintigraphy is a disease-ac- tivity parameter in Graves' ophthalmopathy显示文摘Gerding MN van der Zant FM van der Royen EA 1999Clin Endocrinol1999,50,:1
5Octreotidescintigraphy is a disease-activity parameter in Graves ophthalmopathy显示文摘Gerding MN van der Zant FM van Royen EA 1999Clin Endocrinol (Oxf)1999,50,3:1
618F- 18F- PET/ bone with prostate cancer显示文摘Wondergem N van der FM van der Ploeg T et 1 literature review of fluoride PET/eT and choline or llC-choline cr for detection of metastases in patients Zant al 2013Nucl Med Commun2013,34,10:1
7Octreotide-scintigraphy is a disease activity parameter in Graves'ophthalmopathy显示文摘Gerding MN Van der Zant FM Van Royen EA 1999Clin Endocrinol1999,50,3:1
8A lit- erature review of 18F-fluoride PET/CT and lSF-choline of 11C- choline PET/CT for detection of bone metastases in patients with prostate cancer显示文摘Wondergem M van der Zant FM van der Ploeg T 2013Nucl Meal Commun2013,34,109:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费